HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,217 | -10.8% | 33,213 | +0.5% | 0.00% | – |
Q2 2023 | $38,351 | -26.7% | 33,063 | -4.6% | 0.00% | – |
Q1 2023 | $52,338 | -41.7% | 34,659 | -3.4% | 0.00% | – |
Q4 2022 | $89,715 | -54.9% | 35,881 | -23.9% | 0.00% | – |
Q3 2022 | $199,000 | +49.6% | 47,179 | -0.9% | 0.00% | – |
Q2 2022 | $133,000 | -52.8% | 47,607 | -3.5% | 0.00% | – |
Q1 2022 | $282,000 | -40.6% | 49,327 | -5.2% | 0.00% | -100.0% |
Q4 2021 | $475,000 | -30.5% | 52,038 | -18.5% | 0.00% | 0.0% |
Q3 2021 | $683,000 | -50.8% | 63,860 | -28.5% | 0.00% | -50.0% |
Q2 2021 | $1,387,000 | -1.8% | 89,366 | +2.6% | 0.00% | 0.0% |
Q1 2021 | $1,412,000 | -9.8% | 87,125 | +17.8% | 0.00% | -33.3% |
Q4 2020 | $1,565,000 | +32.2% | 73,959 | -7.4% | 0.00% | +50.0% |
Q3 2020 | $1,184,000 | +1.3% | 79,868 | +0.5% | 0.00% | -33.3% |
Q2 2020 | $1,169,000 | -30.8% | 79,461 | -45.1% | 0.00% | -40.0% |
Q1 2020 | $1,689,000 | -44.5% | 144,735 | +11.3% | 0.01% | -16.7% |
Q4 2019 | $3,045,000 | +49.4% | 129,990 | +18.9% | 0.01% | +20.0% |
Q3 2019 | $2,038,000 | +0.5% | 109,320 | +0.8% | 0.01% | 0.0% |
Q2 2019 | $2,027,000 | +48.0% | 108,461 | +90.9% | 0.01% | +25.0% |
Q1 2019 | $1,370,000 | +25.3% | 56,803 | +101.9% | 0.00% | +33.3% |
Q2 2018 | $1,093,000 | – | 28,134 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|